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Abstract
The complex interplay between the response regulator ComA, the anti-activator RapF, and the signaling peptide PhrF
controls competence development in Bacillus subtilis. More specifically, ComA drives the expression of genetic competence
genes, while RapF inhibits the interaction of ComA with its target promoters. The signaling peptide PhrF accumulates at
high cell density and upregulates genetic competence by antagonizing the interaction of RapF and ComA. How RapF
functions mechanistically to inhibit ComA activity and how PhrF in turn antagonizes the RapF-ComA interaction were
unknown. Here we present the X-ray crystal structure of RapF in complex with the ComA DNA binding domain. Along with
biochemical and genetic studies, the X-ray crystal structure reveals how RapF mechanistically regulates ComA function.
Interestingly, we found that a RapF surface mimics DNA to block ComA binding to its target promoters. Furthermore, RapF
is a monomer either alone or in complex with PhrF, and it undergoes a conformational change upon binding to PhrF, which
likely causes the dissociation of ComA from the RapF-ComA complex. Finally, we compare the structure of RapF complexed
with the ComA DNA binding domain and the structure of RapH complexed with Spo0F. This comparison reveals that RapF
and RapH have strikingly similar overall structures, and that they have evolved different, non-overlapping surfaces to
interact with diverse cellular targets. To our knowledge, the data presented here reveal the first atomic level insight into the
inhibition of response regulator DNA binding by an anti-activator. Compounds that affect the interaction of Rap and Rap-
like proteins with their target domains could serve to regulate medically and commercially important phenotypes in
numerous Bacillus species, such as sporulation in B. anthracis and sporulation and the production of Cry protein endotoxin
in B. thuringiensis.
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Introduction
Two-component signaling systems, consisting of a sensor
histidine kinase and a response regulator transcription factor, are
the principal mechanism of signal transduction in bacteria [1].
Upon phosphorylation of their receiver (REC) domains, response
regulators bind target DNA promoters and activate or repress
transcription. A number of auxiliary factors have garnered
significant attention because they function as anti-activators that
inhibit response regulator function without affecting their
phosphorylation state. These proteins inhibit the interaction of
response regulators with their target promoters [2–5] or RNA
polymerase [6,7]. To our knowledge, the X-ray crystallographic,
biochemical, and genetic results presented here show for the first
time how an anti-activator structurally inhibits the binding of a
response regulator to DNA.
The Rap proteins are a family of auxiliary factors that have
been most thoroughly studied in Bacillus subtilis, where they
regulate two-component and phosphorelay signal transduction.
Despite their relatively high sequence similarity, different Rap
proteins exert their influence on these pathways via disparate
activities [5]. Rap proteins ultimately influence diverse B. subtilis
developmental and cellular differentiation processes including
sporulation, genetic competence, and biofilm formation, as well as
the production of secreted enzymes and the movement of a
conjugative transposon [8,9].
B. subtilis encodes 11 Rap proteins on its chromosome and
another five on plasmids [10–12]. Rap proteins were named after
the founding members of the family, which were shown to be
response regulator aspartate phosphatases [13]. Rap proteins
including RapA, RapB, RapE, RapH, and RapJ are phosphatases
that dephosphorylate the intermediate response regulator Spo0F,
which consists solely of a REC domain [5,13–15]. In contrast,
genetic and biochemical results show that a subset of Rap proteins,
including RapC, RapF, and RapH, are anti-activators that bind to
the response regulator transcription factor ComA, inhibiting its
interaction with DNA promoters without affecting its phosphor-
ylation state (Figure 1) [2,3,5]. Additional genetic results also
suggest that RapD, RapG, and RapK may inhibit ComA as well
[16–18]. Similarly, B. subtilis RapG inhibits the binding of the
response regulator transcription factor DegU to its target
promoters [4]. Consistent with the inability of the Rap proteins
to dephosphorylate ComA or DegU, it was previously shown that
RapC, RapF, and RapH interact stably with the ComA helix-
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domain [2,5].
Secreted signals called Phr peptides contribute to the complexity
of Rap protein signaling. Phr peptides are imported into the cell,
where they bind to Rap proteins and antagonize their activity
(Figure 1) [19,20]. Mature Phr peptides are generated from
immature pro-Phr polypeptides [21,22]. The genes encoding the
pro-Phr polypeptides overlap with the 39 end of the rap genes,
forming rap-phr gene cassettes. Pro-Phr polypeptides are secreted
from the cell and subsequently undergo proteolytic maturation.
Mature Phr peptides are then imported into the cell, where each
peptide inhibits its cognate Rap protein (e.g., PhrA inhibits RapA,
and PhrC inhibits RapC) and in some cases a non-cognate Rap
protein [23–25].
To demonstrate how anti-activators such as the Rap proteins
inhibit the binding of response regulators to target DNA
promoters, we determined the X-ray crystal structure of a B.
subtilis Rap protein, RapF, in complex with the DNA binding
domain of the response regulator ComA (ComAC). As expected,
comparison of the RapF-ComAC crystal structure with the
previously determined structure of RapH-Spo0F [15] revealed
that RapF and RapH are structurally similar; however, ComAC
and Spo0F bind to RapF and RapH, respectively, at distinct, non-
overlapping sites. Furthermore, we show that RapF is monomeric
either alone or in complex with PhrF, and that RapF undergoes a
conformational change upon binding PhrF that is likely the cause
of ComA dissociation from RapF-ComA complexes. Finally, we
propose a model that explains the long-standing observation that
some Rap proteins dephosphorylate response regulator REC
domains while others sequester response regulator HTH DNA
binding domains.
Figure 1. The B. subtilis competence signal transduction pathway. ComP autophosphorylates in response to binding the quorum-sensing
signal ComX and subsequently phosphorylates ComA. ComA,P drives transcription of the srfA operon that in turn triggers the expression of late-
stage competence genes. RapC, RapF, and RapH inhibit the binding of ComA to its target promoters, repressing the induction of genetic
competence. Mature Phr peptides are generated proteolytically from pro-Phr proteins during export. The Spo0K permease (not pictured) imports Phr
peptides into the cytoplasm where they antagonize Rap protein function. H, histidine; D, aspartic acid; P, phosphoryl group.
doi:10.1371/journal.pbio.1001226.g001
Author Summary
Upon phosphorylation, bacterial proteins called response
regulators bind to DNA promoters and activate or repress
transcription. These response regulators are themselves
regulated by anti-activator proteins, which can control
response regulator activity without altering their phos-
phorylation state. We have determined the X-ray crystal
structure of the anti-activator RapF complexed with the
DNA-binding domain of the response regulator ComA. Our
structure-function studies show that RapF disrupts the
binding of ComA to DNA using a two-pronged mecha-
nism. First, a RapF surface mimics DNA, and this DNA-like
surface binds to nearly all of the ComA DNA-binding
residues, thus blocking ComA’s interaction with DNA.
Second, RapF inhibits ComA dimerization. RapF is also
regulated by the PhrF peptide; we find that the RapF-
ComA interaction surface is distant from the proposed
PhrF binding site. Furthermore, we found that RapF
undergoes a conformational change upon binding to
PhrF, which likely causes its dissociation from ComA. From
these observations, we conclude that PhrF binding to RapF
allosterically triggers its dissociation from ComA. Finally,
we compared the RapF/ComA DNA-binding domain
complex structure with the structure of another response
regulator, Spo0F, complexed with the phosphatase RapH.
This reveals that while RapF and RapH are structurally
similar, they have evolved distinct, non-overlapping
surfaces to interact with their different cellular targets.
Bacterial Anti-Activator Structure and Function
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Overall Structure of the RapF-ComAC Complex
To begin to determine how RapF inhibits response regulator
binding to DNA without affecting its phosphorylation state, we
solved its X-ray crystal structure in complex with ComAC to
2.30 A ˚ resolution (Figure 2A and Table S1). The crystallographic
asymmetric unit contains one molecule of RapF bound to one
molecule of ComAC. It is worth noting that the RapF-ComAC
crystallization conditions are identical to conditions that yield
crystals in our initial screens containing RapF and full-length
ComA (ComAFL). However, RapF-ComAFL crystals diffracted
anisotropically and to very low resolution. Presumably, the ComA
N-terminal REC domain, which does not interact with RapF [2],
is responsible for the disorder observed in the RapF-ComAFL
crystals.
RapF Structure
RapF consists of two distinct domains, an N-terminal
antiparallel 3-helix bundle (residues 7–72) and a C-terminal
tetratricopeptide repeat (TPR) domain (residues 92–381)
(Figure 2B). The RapF N-terminal 3-helix bundle consists of two
similarly sized helices, a1 (residues 8–23) and a2 (residues 26–42),
and a significantly longer third helix, a3 (residues 47–72). The 3-
helix bundle and TPR domain are connected by an elaborate
linker region (residues 73–91), containing a 310 helix (residues 75–
77) joined by a short loop (residues 78–80) to helix a4 (residues 81–
91). As discussed in detail below, the N-terminal 3-helix bundle
and the linker region form the ComAC binding surface
(Figures 2C, 3A, and 3B). The RapF C-terminal TPR domain
contains seven helix-turn-helix (HTH) folds that assemble into a
large superhelix. HTH folds 1–5 and 7 are bona fide TPR folds
containing TPR signature sequences (Figure 2B) [26]. The sixth
HTH fold lacks the TPR signature motif but perpetuates the TPR
superhelix. Therefore, we refer to the entire C-terminal region
containing seven tandem HTH folds as the TPR domain.
RapF-ComAC Interface
The RapF-ComAC X-ray crystal structure reveals an extensive
protein-protein interface that buries a total of 1,845.7 A ˚ 2 surface
area (Figures 3A and 4A). The structure of ComAC and its
interaction with target binding sites within the srfA promoter were
previously studied using NMR spectroscopy [27]. The RapF-
ComAC crystal structure shows that most of the ComA residues
that interact with the DNA phosphate backbone, including
Ser181, Ser184, Tyr187, Ser188, and Thr190, are buried in the
RapF-ComAC interface (Figures 4B, 4C, and S1 and unpublished
data). Furthermore, both of the ComA residues shown to interact
with the DNA major groove, specifically Arg183 and Tyr187, are
buried in the RapF interface (Figures 4C, S1, and S2).
In sum, the RapF-ComAC interaction buries six of the seven
ComA DNA binding residues. It is also notable that in addition to
interacting with ComA DNA binding residues, RapF mediates
extensive interactions with ComAC residues not directly involved
in DNA binding. As described in detail below, we rigorously tested
the functional importance of the crystallographically observed
RapF-ComAC interface both in vitro and in vivo.
Functional Analysis of the RapF-ComA Interface In Vitro
To begin to test the functional significance of the RapF-ComA
interactions observed in the RapF-ComAC crystal structure, we
generated RapF mutants containing individual alanine substitu-
tions at RapF-ComA interfacial positions (Figures 3B and S1), and
native PAGE was used to examine the binding of the RapF
mutants to wild-type full-length ComA (Figure 3C). RapF Asp28
hydrogen bonds to the ComA Arg157 and Thr155 side chains,
and RapF Leu67 forms a hydrophobic interaction with ComA
Tyr187 (Figure S1). Consistent with these observations, RapF-
D28A and RapF-L67A exhibited a complete loss of ComA
binding activity (Figure 3C). Furthermore, RapF P27A forms a
hydrophobic interaction with ComA Ile161 and Ser188, and
RapF Gln78 hydrogen bonds with ComA Asn194 and with a
water molecule at the RapF-ComA interface (Figure S1).
Compared to the interaction of wild-type RapF with ComA, the
interaction of RapF-P27A and RapF-Q78A with ComA was
significantly reduced (Figure 3C).
In addition to the RapF mutants evaluated above, we analyzed
the binding of RapF-F24A to wild-type ComA (Figure 3C). RapF
Phe24 is located in the loop connecting RapF helices a1 and a2
(Figure 3B). Its main-chain carbonyl oxygen forms a hydrogen
bond with the ComA Ser191 side-chain hydroxyl, and its carbonyl
carbon atom mediates hydrophobic interactions with ComA
Lys195 (Figure S1). Native gel analysis showed that the F24A
mutation in RapF results in a complete loss of ComA binding
(Figure 3C). While a portion of the RapF Phe24 side chain and
main chain are buried in the ComA interface, the rest of its side
chain is buried in a hydrophobic pocket formed by residues in
RapF helices a3 and a4. We propose that the interaction of the
RapF Phe24 side chain with RapF helices a3 and a4 is essential
for the RapF-ComA interaction because it (1) positions the RapF
Phe24 main chain carbonyl for interaction with ComA and (2)
mediates the packing of the RapF 3-helix bundle and linker, which
both in turn interact with ComA. Also consistent with this
hypothesis, Phe24 is conserved in the Rap proteins previously
shown to bind ComA directly [2,3,5].
One RapF mutant, RapF-E71A, exhibited a significant but
subtler ComA-binding defect than the other RapF mutants tested
(Figures 3C and unpublished data). While RapF Glu71 mediates
contacts with ComAC (Figure S1), it is located at the periphery of
the RapF-ComA interface where it is exposed to bulk solvent.
Consistent with previous studies of protein-protein interfaces (see,
for example, [28]), interfacial residues such as RapF Glu71 that
are exposed to bulk solvent routinely have little impact on the free
energy of binding.
In addition to the RapF mutants described above, we
engineered full-length ComA mutants containing single alanine
substitutions at the RapF-ComAC interface (Figures 4A–C and
S2). The binding of the ComA mutants was then evaluated using
native PAGE (Figure 4D). ComA Arg183 forms a salt bridge with
RapF Glu71 (Figures S1 and S2), and it also interacts
intramolecularly with Tyr187, which is also in the RapF interface.
ComA-R183A displayed a nearly complete loss of RapF binding,
while numerous other ComA mutants, including ComA-Y187A,
ComA-T190A, and ComA-N194A, displayed significantly re-
duced RapF binding activity compared to wild-type ComA
(Figures 4D and S2). Only one mutant tested, ComA-R157A,
appeared to bind RapF with a similar affinity to wild-type ComA
(Figure 4D). As described above, ComA Arg157 and ComA
Thr155 hydrogen bond to RapF Asp28 (Figure S1). ComA-
T155A was insoluble and therefore could not be studied in vitro,
but it is likely that the interaction of ComA Thr155 and RapF
Asp28 is primarily responsible for the complete loss-of-function
displayed by RapF-D28A (Figure 3C). Finally, we estimate based
on the results of the qualitative analysis (Figures 3C and 4D) and
additional native PAGE binding studies employing a broad
concentration range of RapF and a fixed quantity of ComA
(unpublished data) that the dissociation constant (Kd) for RapF-
ComA complex formation is in the 1–10 mM range.
Bacterial Anti-Activator Structure and Function
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To confirm that the RapF-ComA interface observed in the
crystal structure is important for the regulation of ComA activity
in vivo, we overexpressed RapF mutants containing single alanine
substitutions in RapF-ComA interfacial positions and evaluated
their affects on ComA transcriptional activity in B. subtilis
(Figure 3D). More specifically, we measured RapF activity as a
function of ComA-driven srfA transcription using the Photinus
pyralis luciferase gene fused to the srfA promoter. As previously
described, P. pyralis luciferase activity corresponds closely with the
rate of its transcription in B. subtilis [15,29].
The PsrfA-luc reporter bioassay shows that srfA expression is
delayed in proportion to the amount of RapF induced (Figure
S3A). However, we questioned why srfA was expressed at all
considering the fact that the cells overexpressed RapF, which
inhibits ComA-driven srfA expression. We hypothesized that PhrF
expressed from its endogenous locus (Figure S4) was antagonizing
RapF activity. To confirm that this was the case, we overexpressed
a RapF mutant, RapF-D194N, which contains a mutation
previously shown to render RapA and RapC immune to the
effects of their cognate Phr peptides [3,13]. Indeed, overexpressed
RapF-D194N completely suppressed PsrfA-luc expression through-
out the course of the entire experiment (unpublished data).
Moreover, when we added synthetic PhrF peptide to the PsrfA-luc
reporter strain overexpressing RapF, PsrfA-luc expression was
indistinguishable from the non-induced control (Figure S3B).
Together, these results show that overexpressed RapF is
antagonized at least to some degree by PhrF expressed from its
endogenous locus. Nonetheless, overexpressing RapF significantly
delays srfA-luc expression. Consistent with these results and as
described below, strains overexpressing RapF proteins containing
mutations in the RapF-ComA interface should express srfA-luc at
earlier time points than the wild-type RapF control.
Mirroring the results of the RapF-ComA binding studies, RapF-
D28A and RapF-L67A displayed a loss-of-function, and RapF-
P27A and RapF-Q78A displayed intermediate phenotypes
(Figure 3D). Also consistent with the in vitro results (Figures 3C),
RapF-E71A displays a slight loss of function in vivo (Figure 3D).
Western blotting confirmed that the RapF mutants were produced
at levels comparable to wild-type RapF (unpublished data). Thus,
the results of the RapF-ComA in vitro binding studies and the
RapF-ComA luciferase bioassays show that the RapF-ComA
interface identified in the RapF-ComAC crystal structure is
functionally important in vitro and in vivo.
RapF-ComA Stoichiometry
RapF dimerizes around a crystallographic 2-fold symmetry axis
in the RapF-ComAC crystals. To begin to determine whether
RapF also dimerizes in solution, we analyzed RapF and RapF-
ComA complexes by gel filtration (Figure 5A). The results of these
studies suggested that RapF alone and RapF in complex with
ComA could be forming dimers in solution (Table 1). However,
molecular weight determination using gel filtration becomes less
reliable as the shape of the analyzed protein or protein complex
deviates from that of a sphere, and RapF has an elongated
structure (Figure 2A). In fact, RapF is approximately twice as long
as it is wide, and its shape more closely resembles a rod than a
sphere. Therefore, to determine unambiguously whether RapF
dimerizes in solution, we studied RapF using sedimentation-
equilibrium (SE) analytical ultracentrifugation (AUC). The
theoretical molecular weight of a RapF monomer is 46.3 kD,
and its molecular weight as determined by SE AUC is 47 kD
(Figure 5B and Table 1). Therefore, we conclude that RapF is
monomeric in solution.
The RapF-ComAC crystallographic asymmetric unit (Figure 2A)
contains one molecule of RapF bound to one molecule of ComAC,
suggesting that perhaps a monomer of RapF binds to a monomer
of ComA in solution. However, ComA alone and ComAC alone
homodimerize in solution (Figure 5A, Table 1) [27,30], and ComA
dimers bind to DNA regulatory sites composed of three
recognition elements [30]. Therefore, we examined whether RapF
is binding a ComA monomer or dimer in solution using gel
filtration in combination with total amino acid analysis and SE
AUC. A mixture of RapF and ComA was passed over a gel
filtration column and total amino acid analysis was performed on
the RapF-ComA complex fractions as described in Materials and
Methods. The results of the total amino acid analysis (unpublished
data) indicate that the stoichiometry of the RapF-ComA complex
is 1:1. Finally, SE AUC analysis of the identical RapF-ComA
sample indicated the formation of a single species of approximately
74 kD (Figure 5B). This is consistent with a complex composed of
one molecule of RapF (45.7 kD) and one molecule of ComA
(26.3 kD) (Table 1).
Together, the results of the SE AUC, gel filtration chromatog-
raphy combined with total amino acid analysis, and X-ray
crystallography suggest that a monomer of RapF binds to a
monomer of ComA or ComAC, and that the stoichiometries of the
RapF-ComA and RapF-ComAC complexes are 1:1. In Figure 5F,
ComAC from the RapF-ComAC X-ray crystal structure is aligned
with a molecule of ComAC from the dimeric ComAC NMR
structure [27]. While the RapF-ComAC structure shows that
RapF-bound ComAC undergoes conformational changes near the
ComAC dimerization interface, we cannot rule out the possibility
that these changes were influenced by lattice contacts involving
ComAC. Nonetheless, consistent with the RapF-ComAC crystal
structure, we find that RapF binds to a ComA monomer in
solution. Furthermore, while RapF does not interact with ComAC
dimerization interface residues, which are located in helix a8, a10,
and the a7–a8 loop (Figure 5F), we hypothesize that the RapF-
induced ComAC conformational change is transmitted to ComA
a10 through contacts between RapF and ComA residues in the C-
terminus of a9 (residues N194 and K195) and the a9–a10 loop
(residues N197, V198, and G199) (Figure 5F). In fact, RapF Gln78
and RapF Phe24 contact ComA Asn194 and Lys195, respectively,
and RapF-Q78A and RapF-F24A both exhibited severe ComA
binding defects (Figure 3C). Despite the numerous contacts
between RapF and ComA residues directly adjacent to the
ComAC dimerization interface, because RapF does not interact
with the surface of the ComAC dimerization interface, we
conclude that RapF allosterically inhibits ComAC dimerization.
RapF Undergoes a Conformational Change Upon Binding
to PhrF
The gel filtration analysis of RapF-ComA and RapF performed
above (Figure 5A) were repeated in the presence of PhrF
(Figure 5C, 5E and Table 1). Consistent with previous native-
PAGE studies [2], we found that PhrF caused the dissociation of
the RapF-ComA complex (Figure 5E and Table 1). Also consistent
Figure 2. RapF-ComAC structure. (A) The RapF-ComAC crystallographic asymmetric unit. (B) RapF domain architecture with a-helices depicted as
cylinders. HTH, helix-turn-helix. (C) RapF-ComAC oriented as in panel B and looking down the helical axis of the principal ComA DNA binding helix a9.
RapF residues buried in the RapF-ComAC interface are colored magenta.
doi:10.1371/journal.pbio.1001226.g002
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band was observed in the presence of PhrF, we found that PhrF
caused RapF to elute at a significantly higher volume than RapF
alone (Figure 5C, 5E, and Table 1). However, in the previous
native PAGE studies it was assumed that RapF was dimeric [2],
and why a faster migrating band appeared in the presence of PhrF
was unknown.
As discussed above, SE AUC shows that RapF alone is
monomeric (Figure 5B and Table 1). Consistent with this result,
the molecular weight of RapF complexed with PhrF is 50 kD as
determined by SE AUC (Figure 5D and Table 1), and there is no
change in RapF stoichiometry upon binding to PhrF. Therefore,
we conclude that RapF migrates through the gel filtration matrix
radically slower in the presence of PhrF than in its absence, and
RapF migrates faster in the presence of PhrF when analyzed by
native PAGE [2], because it undergoes a large conformational
change upon binding to PhrF.
Discussion
Response regulators are the primary mechanism for converting
sensory perception into transcriptional output in bacteria. How
auxiliary factors such as the Rap proteins function structurally to
inhibit response regulator binding to DNA promoters was not
known. The X-ray crystallographic, biochemical, and genetic
results presented here reveal that RapF disrupts response regulator
binding to DNA using a two-pronged mechanism. First, RapF
buries ComA DNA binding residues in the RapF-ComA interface,
sterically blocking the binding of ComA to its DNA recognition
elements. Second, RapF binding allosterically weakens the
ComAC dimerization interface, inhibiting the formation of
transcriptionally active ComA dimers (Figure 5B). In theory, each
mechanism alone could effectively inhibit response regulator
activity; however, RapF uses both.
To our knowledge, the data presented here reveal the first
atomic level insight into the inhibition of response regulator DNA
binding by an anti-activator. However, the structures or regulatory
mechanisms of other anti-activators and anti-repressors that target
transcription factors other than response regulators have been
described, for example TraM, CarS, TrlR, AppA, and ExsD
(Figure S5) [31–35]. These proteins repress the activity of their
targets by (1) directly blocking the interaction of DNA binding
residues and DNA, (2) inhibiting their functionally required
multimerization, or (3) causing allosteric rearrangements that
preclude their binding to DNA. RapF does not share obvious
structural similarities with these anti-activators and anti-repressors
(Figure S5); however, a comparison of the structural and
functional data available for the different systems is informative.
The TraR-TraM crystal structure showed that the anti-
activator TraM interacts with the TraR N-terminal dimerization
domain (NTD) in addition to its C-terminal DNA binding domain
(CTD) and linker region connecting the NTD and CTD (Figure
S5) [35]. In contrast to the interactions observed in the RapF-
ComAC structure, TraM does not contact the TraM DNA binding
residues. Rather, TraM allosterically regulates TraR activity.
CarS-CarA interactions were mapped using NMR chemical
shift perturbation and site-directed mutagenesis studies [31].
Interestingly, like RapF (discussed below), the anti-repressor CarS
mimics DNA to interact with its target’s DNA binding domain;
however, the RapF and CarS folds are entirely different (Figure
S5). While RapF is entirely alpha helical, CarS resembles an SH3
domain and consists of an antiparallel beta sheet and a 310 helix.
How TrlR, AppA, and ExsD function structurally to regulate
their targets is not as well understood as it is for the systems
discussed above. However, it was shown that TrlR is a truncated
form of TraR that regulates TraM by forming inactive TrlR-TraR
dimers [32], and that the flavin binding protein AppA inhibits
PpsR repressor activity by reducing a disulphide bond in PpsR and
forming inactive AppA-PpsR2 complexes [36]. Finally, how ExsD
functions structurally to inhibit ExsA transcriptional activity is
unknown, and different studies suggest that ExsD interacts stably
with either the ExsA N-terminal oligomerization domain alone
[37] or only the intact full-length protein [38].
ComA is a member of the LuxR/FixJ/NarL family of
transcriptional regulators whose HTH DNA-binding domains
are tetra-helical bundles [39,40]. Aligning ComAC of the RapF-
ComAC structure with a molecule of NarLC of the NarLC-DNA
complex structure (1JE8) revealed that RapF’s ComA-binding
surface adopts a conformation reminiscent of a DNA major groove
(Figure 6A and 6B) [41,42]. Additionally, analogous to DNA, at
the core of the RapF ComAC-binding surface, there is a large
electronegative patch (Figure 6C) [43]. Moreover, six of the seven
previously identified ComA DNA binding residues are buried in
the RapF-ComAC interface. For example, the sidechain of ComA
Arg183 forms a salt bridge with the side chain of RapF Glu71, and
the side chain of ComA Thr190 forms a hydrogen bond with the
side chain of RapF Glu71 (Figure S2). These contacts appear to
mimic the hydrogen bonds that the ComA residues make with the
DNA major groove and phosphate backbone, respectively [27].
Thus, the RapF-ComAC X-ray crystal structure reveals that
ComA binds to a RapF surface that, at least in part, mimics DNA.
HTH DNA binding domains are ubiquitous in all three
superkingdoms of life [39]. In fact, B. subtilis alone encodes 10
proteins containing tetra-helical bundle HTH domains similar to
the ComA DNA binding domain [44]. The identity of residues in
helix a9 and the a8–a9 loop are primarily responsible for
determining LuxR/FixJ/NarL-type HTH DNA recognition
element specificity [27,41,45,46]. For example, ComA Tyr187 in
helix a9 inserts into the DNA major groove and contacts the
phosphate backbone [27], while no other B. subtilis response
regulator encodes tyrosine at the equivalent position (Figure 6D).
Similarly, ComA Arg183 and Thr190 insert into the DNA major
groove and contact the phosphate backbone, respectively. Only
one other B. subtilis response regulator, YdfI, encodes identical
residues at these positions (Figure 6D). YdfI is in fact the B. subtilis
protein containing a LuxR/FixJ/NarL-type HTH domain most
highly homologous to ComAC, yet they bind to different DNA
recognition elements [30,47]. Interestingly, we found that purified
RapF and YdfI did not stably interact (unpublished data). We
propose that Rap protein interactions with the HTH DNA
Figure 3. In vitro and in vivo activity of RapF mutants targeting the RapF-ComA interface. (A) RapF (blue cartoon) in complex with
ComAC (brown surface). (B) Expanded view of the area enclosed by the black square in panel A. RapF residues targeted for in vitro or in vivo
functional analysis are depicted as magenta sticks. (C) Native PAGE analysis of RapF-ComA complexes. (D) In vivo activity of RapF and RapF mutants
targeting the RapF-ComA interface measured as a function of PsrfA-luc. The inset panel shows that the PsrfA-luc strains exhibited similar ComA
activity in the absence of induced RapF. Each curve is representative of at least three independent experiments performed in duplicate. T0 is the time
of transition from exponential growth to the stationary phase. Western blotting showed that RapF was overexpressed from the Pspank(hy) promoter
at 2.5 times the level of endogenously produced RapF at T0 (unpublished data). RLU, Relative Luminescence Units.
doi:10.1371/journal.pbio.1001226.g003
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regulators with their DNA recognition elements. Contacts with
these DNA binding residues may enable Rap proteins to
preferentially recognize their response regulator targets, e.g.
ComA or DegU, among the myriad B. subtilis HTH DNA binding
domains.
Figure 4. In vitro binding of wild-type RapF to His-ComA mutants targeting the RapF-ComA interface. (A) RapF (blue surface) in
complex with ComAC (brown cartoon). (B) Expanded view of the area enclosed by the black rectangle in panel A. (C) RapF interaction with the
principal ComA DNA binding helix a9 (brown helix). (D) The binding of wild-type RapF to His-ComA mutants corresponding to the residues depicted
as magenta sticks in panels B and C was determined by native PAGE.
doi:10.1371/journal.pbio.1001226.g004
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PLoS Biology | www.plosbiology.org 9 December 2011 | Volume 9 | Issue 12 | e1001226Some Bacillus Rap proteins are phosphatases that bind to and
dephosphorylate Spo0F, a stand-alone REC domain, while others
bind to the HTH DNA binding domain of the response regulator
ComA rather than its REC domain [2,5,15]. Structural alignment
of RapF of the RapF-ComAC structure with RapH of the RapH-
Spo0F structure (3Q15) showed that their tertiary structures are
essentially identical, and they align with a root mean-square
deviation of 1.61 A ˚ (Figure 7A–C) [15]. Remarkably, this
alignment also revealed that ComAC and Spo0F bind to non-
overlapping Rap protein surfaces (Figure 7C). ComAC interacts
only with the RapF linker region and 3-helix bundle, while Spo0F
interacts with the RapH TPR domain and 3-helix bundle at a site
distant from the ComAC binding site on the RapF 3-helix bundle.
Rap proteins have not been observed to bind simultaneously to
both the REC and HTHDNAbindingdomains of a single response
regulator. However, it is possible that an ancestral Rap protein did
in fact interact with both domains. The Spo0F (REC) and ComAC
(HTH) binding sites do not overlap, and a Rap protein could
theoretically bind to both a REC and HTH domain concurrently
(Figure 7C). Alternatively, there may not have been an ancestral
Rap protein that could bind a REC and HTH DNA binding
domain. In this case, the fact that Rap proteins commonly target
one or the other of two domains found in response regulator
transcription factors could be a coincidence resulting from
independentevolutionofRapproteininteractionswith theirtargets.
Furthermore, we speculate that Rap proteins such as RapC,
RapF, and RapH may have evolved to interact stably with the
ComA HTH domain but not its REC domain [2,5] because the
short linker connecting them precludes their simultaneous
interaction with the relevant Rap protein binding sites. Indeed,
structural alignment of RapF of the RapF-ComAC structure with
RapH of the RapH-Spo0F structure shows that the C-terminus of
Spo0F and the N-terminus of ComAC are separated by greater
than 49 A ˚. Rap proteins could interact with the REC and HTH
domain of a single response regulator simultaneously if the
domains were connected by a long linker as found in the B. subtilis
uncharacterized protein YesN, or an additional domain common
to the response regulators in the NtrC family [40,44]. However,
the relatively short linker region connecting the ComA REC and
HTH domains would prevent their simultaneous interaction with
the identified Rap protein REC [15] and HTH domain binding
sites (Figure 7C).
Previous work suggests that Phr peptides may bind to the Rap
protein TPR domain [3,13,24], and it was hypothesized that
response regulators may compete with Phr peptides for binding to
a common site on the TPR domain [3]. However, the RapF-
ComAC X-ray crystal structure shows that the RapF TPR domain
does not in fact contact ComAC. RapF-ComAC contacts are
mediated only by the RapF 3-helix bundle and linker region.
Thus, it appears that PhrF may allosterically inhibit the RapF-
ComA interaction, and the dissociation of RapF and ComA
presumably results from the PhrF-induced conformational change
in RapF (Figure 5C and 5E). The Rap protein conformational
changes induced by Phr peptide binding are currently unknown,
and it seems likely that crystal structures of Rap proteins in their
Phr peptide bound conformations will be required to reveal these
conformational changes as well as the mechanistic nature of the
Rap-Phr interaction.
Furthermore, in regard to Rap protein stoichiometry, it is worth
noting that RapH dimerizes around a crystallographic 2-fold
Figure 5. Analysis of RapF complexes in solution. (A) Size exclusion chromatography of RapF (peak elution volume (VR) 14.11 ml), ComA2 (VR
14.75 ml), and RapF-ComA (RapF-ComA VR 13.43 ml, uncomplexed ComA VR 14.80 ml). SDS-PAGE analyses of the indicated fractions are shown
below the traces. The peak positions of gel filtration standards are indicated by vertical lines above the traces. (B) Sedimentation equilibrium data for
50 mM RapF (filled circles) and 50 mM RapF-ComA (open triangles). Centrifugation was carried out at 13,000 rpm (RapF) or 9,000 RPM (RapF-ComA)
and 20uC as described in the Materials and Methods. Bottom, the measured absorbance at 286 nm (RapF) or 285 nm (RapF-ComA) versus the radius
(distance to the center of the rotor) is shown. The continuous line represents the result from a single exponential fit of the data points. Top, the
residuals to the fit expressed as the difference between experimental and fitted values. The residuals for the RapF-ComA sample deviated from zero
in a systematic fashion, suggesting the presence of non-specific interactions probably between weakly associating ComA dimers in buffer A (see
Materials and Methods). (C) Size exclusion chromatography of RapF as in panel A (VR 14.11 ml) and RapF+PhrF (VR 15.12 ml). SDS-PAGE analysis and
peak positions of gel filtration standards are depicted as in panel A. (D) Sedimentation equilibrium data for 50 mM RapF (open circles) mixed with
500 mM PhrF. Top and bottom graphs are depicted as in panel B. Centrifugation was carried out at 13,000 rpm and 20uC as described in Materials and
Methods. The absorbance was measured at 286 nm. (E) Size exclusion chromatography of RapF-ComA as in panel A (RapF-ComA VR 13.43 ml and
uncomplexed ComA2 VR 14.80 ml) and RapF-ComA+PhrF (VR 15.06 ml). Due to their similar size, the RapF-PhrF and ComA2 peaks overlap. SDS-PAGE
analysis and gel filtration standards are depicted similarly as in panel A. See Table 1 for the molecular weights calculated from the SEC and SE AUC
shown in panels A–E. (F) Structural alignment of ComAC from the RapF-ComAC X-ray crystal structure with a molecule of the ComAC homodimer
(2KRF) [27]. The ComAC backbone atoms aligned with a root mean-square deviation of 1.40 A ˚. The dimerization interface consists primarily of
residues in helix a10 and the a7–a8 loop. ComAC residues buried in the RapF-ComAC interface are colored green. For clarity, RapF is omitted.
doi:10.1371/journal.pbio.1001226.g005
Table 1. Molecular weight (M) of ComA, RapF, RapF-ComA, and RapF-PhrF complexes determined by size exclusion
chromatography (SEC) and analytical ultracentrifugation (AUC).
Sample ID MSEC (kD)
a MAUC (kD)
b Monomer Mtheoretical (kD) Dimer Mtheoretical (kD)
ComA 59.160.9 N.D. 26.3 52.6
RapF 90.061.3 47 45.7 91.4
RapF-ComA 139.764.9 74 72.0 144.0
RapF+PhrF 46.760.9 50 46.3 92.6
RapF-ComA+PhrF 49.060.3 N.D. 46.3 (RapF+PhrF), 26.3 (ComA) 92.6 (RapF+PhrF), 52.6 (ComA)
aThe SEC data represent an average of measurements obtained from two independent experiments and were determined as described in Materials and Methods.
bThe AUC data represent the molecular weight determined from the linear fit applied to the ln absorbance (285 nm or 286 nm, as indicated) versus the radius squared
(not shown) of the data presented in Figure 5B and 5D. N.D, not determined.
doi:10.1371/journal.pbio.1001226.t001
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PLoS Biology | www.plosbiology.org 10 December 2011 | Volume 9 | Issue 12 | e1001226Figure 6. RapF mimics DNA. (A) Structural alignment of ComAC of the RapF-ComAC structure with a molecule of NarLC of the NarLC-DNA structure
(1JE8) [41] oriented looking down the helical axis of ComAC helix a9 shows that the RapF ComA binding surface (magenta) resembles the shape of
the DNA major groove. The ComAC and NarLC Ca backbone atoms aligned with a root mean-square deviation of 0.60 A ˚. (B) Top view of the
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migrate through gel filtration matrix in a manner consistent with
that of a dimer ([15] and unpublished data). However, SE AUC
analysis of both RapH and RapK (unpublished data) show that
they are in fact monomeric in solution like RapF. Additional SE
AUC studies are required to determine whether other Rap
proteins are monomeric similar to RapF, RapH, and RapK, or
whether they are dimeric as previously suggested [48].
The results of our X-ray crystallographic studies, SE AUC, and
gel filtration combined with total amino acid analysis suggest that
a RapF monomer binds to a monomer of ComA or ComAC.
However, the reported ComAC homodimerization interface
residues [27] are not buried in the RapF-ComA interface
(Figure 5F). Thus, it is theoretically possible that a molecule of
ComA in a RapF-ComA complex could bind to another molecule
of ComA using its ComAC homodimerization surface. Also, a
molecule of ComA bound to RapF could bind to another molecule
of ComA using its N-terminal receiver domain, which might be
accessible because it does not interact stably with RapF. However,
even if ComA can in fact homodimerize to some extent when
bound to RapF, it is in all likelihood a non-functional ComA
dimer. That is, if each molecule of ComA in a ComA dimer is
required to interact with DNA at a target promoter [30], then
RapF would disable the ComA dimer when it binds directly to and
buries nearly all of the DNA binding residues belonging to one
molecule of ComA.
Rap proteins are proposed to be the most ancient member of
the RNPP protein family [49]. The RNPP proteins are related to
the Bacillus Rap, NprR, and PlcR proteins, as well as the
Enterococcal protein PrgX. These proteins are widespread in
Firmicutes, and a rap-phr cassette was also recently identified
outside of the Firmicute phylum encoded on a plasmid in a highly
multidrug resistant strain of Salmonella enterica serovar Dublin [50].
Structure-function analysis showed that PlcR and PrgX are
transcription factors that contain N-terminal DNA binding
domains and C-terminal TPR or TPR-like domains [49,51].
There are no structural data and very limited functional data
available describing the NprR proteins, which include a number of
proteins in Bacillus and Clostridia. Like PlcR and PrgX, NprR
proteins are transcription factors; however, sequence analysis
suggests that NprR proteins are essentially Rap proteins
containing a tetrahelical bundle HTH DNA binding domain
fused to their N-terminus [20].
We hypothesize that the NprR structure may closely resemble
the structure of RapF-ComAC, except that in the case of NprR the
HTH DNA binding domain is covalently attached to the N-
terminus of the NprR 3-helix bundle. Similar to RapF-ComAC,
DNA binding residues in the NprR HTH DNA binding domain
may be buried in an interface with the NprR 3-helix bundle and
linker region. Like the Rap proteins, NprR, PlcR, and PrgX
activity is regulated by oligopeptides reminiscent of the Phr
peptides (review in [52]). Peptide binding to NprR could disrupt
the interaction of the NprR 3-helix bundle and its DNA binding
domain, triggering NprR transcriptional activity. This mechanism
is analogous to the PhrF-driven dissociation of the RapF 3-helix
bundle and ComA.
In conclusion, we speculate that a protein containing only the
Rap protein 3-helix bundle and linker region may be sufficient to
inhibit the binding of HTH DNA binding domains to DNA.
Engineering this relatively simple scaffold to bind HTH domains
other than those belonging to ComA or DegU would create useful
in vivo tools for studying bacterial signaling. Furthermore, Rap-
Phr and NprR-Phr systems regulate medically and commercially
important phenotypes in numerous Bacillus species, e.g. sporula-
tion in B. anthracis [53] and sporulation and the production of Cry
protein endotoxin in B. thuringiensis [52,54], respectively. There-
fore, compounds that regulate the activity of Rap and Rap-like
proteins could serve as commercially important additives that
modulate the overproduction of insecticidal endotoxins or as
antibacterial drugs.
Materials and Methods
Protein Purification for Crystallization
RapF was overexpressed as an N-terminal fusion to glutathione
S-transferase (GST) in E. coli strain BL21 grown in LB media
supplemented with 100 mg/ml ampicillin. The cultures were first
grown at 37uCt oa nO D 600 of 0.4 and then transferred to 25uC
and induced with 0.1 mM isopropyl b-D-thiogalactopyranoside
(IPTG) at an OD600 of 0.6. After growth for an additional 16 h at
25uC, cultures were harvested by centrifugation at 4,000 RPM,
lysed in Buffer I (20 mM Tris pH 8.0, 150 mM NaCl, 5 mM
DTT) supplemented with 5 mM MgCl2,2 0mg/ml DNaseI, and
2 mM phenylmethylsulfonyl fluoride (PMSF), and insoluble
material pelleted at 22,000 RPM for 90 min. Cleared lysates were
applied to Glutathione-Uniflow Resin (Clontech), equilibrated in
Buffer I. The resin was then washed with Buffer I, resuspended in
4 bed volumes of Buffer I and 3.5 mg/ml thrombin, and incubated
for 1.5 h at 25uC. This procedure resulted in complete cleavage of
the N-terminal GST affinity tag as determined by SDS-PAGE.
Following thrombin cleavage, RapF (residues 1–381) contained
two heterologous residues (Gly-Ser) derived from the thrombin
cleavage signal. RapF was eluted with Buffer I and diluted 2-fold
with Buffer II (20 mM Tris pH 8.0, 5 mM DTT), passed through
a 0.22 mm filter, and loaded onto an anion exchange column
(Source 15Q, GE Healthcare) equilibrated with Buffer II
containing 75 mM NaCl. RapF was eluted in a 75–750 mM
NaCl linear gradient of Buffer II. RapF-containing fractions were
further purified by gel filtration using a Superdex 200 (GE
Healthcare) 16/70 column equilibrated with Buffer II containing
150 mM NaCl. Again, RapF containing fractions were pooled and
concentrated.
ComAC protein (His-ComAC) was purified as described
previously with the following modifications to the protocol [2].
Following Ni-NTA affinity column chromatography, His-ComAC
containing fractions were pooled, diluted 4-fold with Buffer III
(50 mM Tris pH 8.0, 5 mM DTT), passed through a 0.22 mm
filter, and loaded onto an anion exchange column (Source 15Q;
GE Healthcare) equilibrated with Buffer III containing 50 mM
KCl. His-ComAC eluted from the anion exchange column in the
flow through and was concentrated by ultrafiltration (MWCO:
3 kDa). For storage, His-ComAC was exchanged into Buffer IV
alignment shown in panel A obtained by rotating panel A 90u in the direction indicated by the arrow. (C) The RapF electrostatic surface potential was
calculated using APBS [43] and displayed on the solvent-accessible surface. Electronegative and electropositive surfaces are colored red and blue,
respectively, and contoured from 25t o+5 kT/e. (D) B. subtilis LuxR/FixJ/NarL-type family member HTH DNA binding domain amino acid sequence
alignment. Highly conserved residues are indicated with blue type. ComA secondary structure assignments are denoted by the black rectangles
above the sequences. ComA residues buried in the RapF interface are indicated with red type. Asterisks and colons above the sequences denote
ComA DNA binding residues and ComAC dimerization interface residues, respectively [27].
doi:10.1371/journal.pbio.1001226.g006
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PLoS Biology | www.plosbiology.org 12 December 2011 | Volume 9 | Issue 12 | e1001226Figure 7. ComAC and Spo0F bind to different Rap protein surfaces. (A) Side view of the RapF-ComAC complex. (B) Side view of the RapH-
Spo0F complex (3Q15) [15]. This view was obtained by aligning RapH of the RapH-Spo0F complex with RapF of the RapF-ComAC complex as oriented
in panel A and as described in (C). Dashed lines denote the RapH disordered region as described below. A comparison of panels A and B shows that
ComAC and Spo0F bind to opposite faces of the RapF and RapH 3-helix bundles, respectively, and that Spo0F also interacts with the RapH TPR
domain. (C) Side view of RapF of the RapF-ComAC structure aligned with RapH of the RapH-Spo0F structure. The RapF and RapH Ca backbone atoms
aligned with a root mean-square deviation of 1.61 A ˚. We previously observed insufficient electron density corresponding to RapH residues 69–76,
and they were not included in the RapH-Spo0F model [15]. These residues correspond to the C-terminus of RapF helix a3 and a portion of the RapF
linker region including the 310 helix. This region appears to be ordered in the RapF structure resulting from extensive interactions with ComA.
Structural alignment of RapF of the RapF-ComAC structure with RapH of the RapH-Spo0F structure also revealed conformational differences in the
regions surrounding the RapF and RapH a2–a3 loops. This area contains residues particularly important for Rap phosphatase activity, including a
catalytic residue that inserts into the Spo0F active site. Thus, the conformational differences between RapF and RapH near the a2–a3 loop likely result
from Spo0F binding to RapH.
doi:10.1371/journal.pbio.1001226.g007
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(EPPS) pH 8.0, 200 mM KCl, 1 mM DTT) using G-25-50
Sephadex (Sigma).
Crystallization and Data Collection
RapF-ComAC crystals were produced by the vapor diffusion
method at 20uC using a 1:1 mixture of RapF:ComAC (100 mM
RapF and ComAC each in its corresponding storage buffer) and
well solution (6% [w/v] PEG 8,000, 240 mM calcium acetate,
80 mM sodium cacodylate pH 6.5, and 20% glycerol). Data were
collected at a wavelength of 1.0750 A ˚ on nitrogen-cooled crystals
at NSLS beamline X29A. Diffraction data were processed using
HKL2000 [55].
Structure Determination, Model Building, and
Refinement
The RapF-ComAC structure was determined by molecular
replacement with PHASER [56] using the N-terminal domain
(residues 4–68) and C-terminal domain (residues 77–376) of RapH
(3Q15) as search models [15]. ComAC was not included in the
search model. The single molecular replacement solution
identified using PHASER was refined in REFMAC5 [57].
ARP/wARP was used to generate an initial model [58], and
iterative cycles of building in COOT [59] and refinement in
PHENIX [60] were performed to complete the model. The final
model lacks only residues 1–5 corresponding to the N-terminus of
RapF, and 146–152 and 211–214 corresponding to the N- and C-
terminus of ComAC, respectively. The building of a single Mn
2+
atom into clear electron density during the final stages of
refinement in PHENIX was justified based on its coordination
to oxygen ligands, i.e. the carbonyl oxygens of RapF Leu40 and
Met43, and the side chain oxygens in the RapF Glu45 side chain,
the metal-oxygen ligand distances, the similarity of the Mn
2+
refined B-factor to those of its surrounding atoms, and the absence
of calculated Fo-Fc difference density surrounding the Mn
2+ ion.
Mn
2+ was not added to the RapF purification or crystallization
buffers and may have been acquired through adventitious buffer
contamination. Secondary structure assignments were calculated
using PROMOTIF [61]. Ramachandran statistics were calculated
in Molprobity [62]. Molecular graphics were produced with
PyMOL [63]. The RapF-ComAC structure has excellent geom-
etry, with 98.4%, 1.6%, and 0% of residues falling within the
favored, allowed, and outlier regions of the Ramachandran plot,
respectively.
Non-Denaturing Polyacrylamide Gel Electrophoresis
10 mM RapF and either 10 mM ComA or 10 mM His-ComA as
indicated were incubated in Buffer A (20 mM Tris pH 8.0,
300 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 5% glycerol) for
30 min at 4uC (see Text S1 for additional details regarding the
purification of ComA and His-ComA). 56 sample buffer was
added to each reaction mixture and samples were analyzed by
native PAGE using 12% Tris-glycine gels. Gels were run under
constant voltage (85 V) for 4 h at 4uC and then stained with
Coomassie Brilliant Blue R-250 (Amresco). The disappearance of
the lower band (ComA) was the primary indicator of complex
formation. The degree of top band (RapF) shifting corresponded
with the disappearance of ComA and provided additional
evidence of RapF-ComA complex formation.
Gel Filtration
Gel filtration runs were performed with RapF, His-ComA, and
PhrF (NH2-QRGMI-COOH) (LifeTein) at 20 mM, 40 mM, and
200 mM, respectively. Prior to analysis, the proteins were
incubated in Buffer A for 30 min at 4uC and filtered by
centrifugation through a 0.22 mm cut-off cellulose acetate filter
(Spin-X; Costar). 100 ml of each sample was injected onto a
Superdex 200 HR10/30 gel filtration column (Amersham
Biosciences) equilibrated in Buffer A. 0.5 ml fractions were
collected and analyzed by SDS-PAGE. Gels were stained with
Coomassie Brilliant Blue R-250. RapF-ComA was prepared for
total amino acid analysis by injecting a mixture containing 40 mM
RapF and 80 mM His-ComA in Buffer A onto a Superdex 200
HR10/30 gel filtration column and collecting fractions spanning
12.0 to 13.5 ml as shown in Figure 5A. The RapF and ComA
bands were separated by SDS-PAGE and excised for total amino
acid analysis at the Keck Biotechnology Resource Laboratory
(Yale).
Sedimentation Equilibrium Analysis
Analytical ultracentrifugation measurements were carried out
on a Beckman XL-A (Beckman Coulter) analytical ultracentrifuge
equipped with an An-60 Ti rotor (Beckman Coulter) at 20uC.
50 mM RapF and 50 mM RapF mixed with 500 mM PhrF were
dialyzed overnight against 20 mM Tris pH 8.0 and 150 mM
NaCl and analyzed at rotor speeds of 13,000 (Figure 5B) and
16,000 rpm (unpublished data). RapF-ComA Superdex 200
HR10/30 gel filtration fractions spanning 12.0 to 13.5 ml as
shown in Figure 5A were dialyzed overnight against Buffer A
minus DTT and analyzed at rotor speeds of 9,000 rpm (Figure 5D)
and 16,000 rpm (unpublished data). Data were acquired at two
wavelengths per rotor speed setting and processed simultaneously
with a nonlinear least squares fitting routine [64]. Solvent density
and protein partial specific volume were calculated according to
solvent and protein composition, respectively [65].
Luciferase Assays
Luciferase assays were performed as previously described with
the following modifications [15]. The PsrfA-luc reporter strains (see
Text S1) were grown in LB medium to an OD600 of 2.0,
centrifuged, and resuspended in fresh Competence Medium (CM)
[66] to an OD600 of 2.0. The cultures were then diluted 20-fold in
fresh CM supplemented with 0.25 mM IPTG to induce expression
of wild-type or mutant rapF from the Pspank(hy) promoter. 200 ml
of the induced cultures were dispensed per well in duplicate in a
96-well black plate (Corning). Luciferin was added to each well at
a final concentration of 0.47 mM. The cultures were then
incubated at 37uC under agitation in a PerkinElmer Envision
2104 Multilabel Reader. The plate lids were heated to 38uCt o
avoid condensation. Relative Luminescence Unit (RLU) and
OD600 were measured at 1.78 min intervals.
Accession Numbers
Atomic coordinates and structure factors for RapF-ComAC
have been deposited in the Protein Data Bank under accession
code 3ULQ.
Supporting Information
Figure S1 Schematic representation of the RapF residues
targeted for mutagenesis and their interactions at the ComA
interface. RapF and ComA residues are depicted with blue and
brown bonds, respectively. Hydrogen bonds are depicted as
dashed green lines. Blue and brown semicircles with radiating lines
depict hydrophobic contacts between RapF and ComA residues,
respectively. The schematic was produced with LIGPLOT [67].
(TIF)
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targeted for mutagenesis and their interactions at the RapF
interface. ComA and RapF residues are depicted with brown and
blue bonds, respectively. Hydrogen bonds are depicted as dashed
green lines. Brown and blue semicircles with radiating lines depict
hydrophobic contacts between ComA and RapF residues,
respectively. The schematic was produced with LIGPLOT [67].
(TIF)
Figure S3 RapF and PhrF regulate the expression of PsrfA-
luciferase. (A) PsrfA-luc activity measured in the absence or presence
of IPTG at the indicated concentrations. (B) Synthetic PhrF
peptide added to the cultures antagonizes the delayed expression
of PsrfA-luc caused by the overexpression of RapF.
(TIF)
Figure S4 B. subtilis upregulates the expression of phrF during the
transition to stationary phase growth (T0). PhrF-luc expression in B.
subtilis growing in competence media (CM) or sporulation media
(DSM). In addition to being driven by a promoter upstream of the
rapF-phrF operon, phrF expression is upregulated during stationary
phase by the stationary phase sigma factor, s
H, whose binding site
lies within rapF [68].
(TIF)
Figure S5 The structures of (A) RapF-ComAC (PDB 3ULQ), (B)
TraR-TraM (2Q0O) [35], (C) CarS (2KSS) [31], (D) the AppA BLUF
domain (2IYG) [33], and (E) ExsD (3FD9) [34]. To our knowledge the
TrlR structure has not yet been determined; however, TrlR is a
truncated form of TraR (panel B) [32].
(TIF)
Table S1 Data collection and refinement statistics. Rsym=Sh Si
|I i(h)2,I(h).|/Sh Si Ii(h), where Ii(h) is the i
th measurement of h
and ,I(h). is the mean of all measurements of I(h) for reflection
h. Rwork=S ||Fo|2|Fc||/S |Fo|, calculated with a working set
of reflections. Rfree is Rwork calculated with only the test set (5.1%)
of reflections. Data for the highest resolution shell are given in
parentheses. The structure was determined using a single crystal.
(DOC)
Text S1 Supplemental Materials and Methods.
(DOC)
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